Company Overview
Company Name
Instylla
Address
Bedford, MA, United States
Website
instylla.comPhone
(781) 555-5555Approx. Annual Revenue
$4.5M
Employees
30
Established
2017
About Instylla
Instylla is a clinical-stage company based in Bedford, Massachusetts, United States, that focuses on developing next-generation liquid embolics for interventional radiology, with initial applications in interventional oncology and peripheral hemostasis. The company is currently conducting a pivotal study for their hypervascular tumor treatment.
Business Profile
Read from the Instylla website on Oct 13, 2026. Hover an item to see the exact wording it came from.
About the website
- Website quality (AI-assessed)
- 8/10 · Current news and FDA approvals; Clear product and clinical information
- Footer copyright year
- 2026
Announcements
As stated on the Instylla website.
- New service“Instylla Initiates Commercial Launch With First Use Of The Embrace™ Hydrogel Embolic System”
Recent changes
What changed on the Instylla website and Google listing, as detected by Coldlytics on each visit.
New service announced
Instylla Initiates Commercial Launch With First Use Of The Embrace™ Hydrogel Embolic System
Coldlytics tracks changes like these across millions of businesses, so you can reach companies the moment they add a pixel, start hiring, or switch software.
Find companies by what just changed →Biotech & Life Sciences Companies near Bedford, MA
Browse all Biotech & Life Sciences companies in Massachusetts →
Frequently Asked Questions about Instylla
Advertising Pixels
- LinkedIn Ad Pixel
Categories
Technologies Used
%20--%3e%3csvg%20version='1.1'%20id='st_x5F_cc_x5F_app_x5F_RGB.svg'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:xlink='http://www.w3.org/1999/xlink'%20x='0px'%20y='0px'%20viewBox='0%200%20240.0004%20234.0004'%20style='enable-background:new%200%200%20240.0004%20234.0004;'%20xml:space='preserve'%3e%3cstyle%20type='text/css'%3e%20.st0{fill:url(%23SVGID_1_);}%20.st1{fill:%23FFFFFF;}%20%3c/style%3e%3clinearGradient%20id='SVGID_1_'%20gradientUnits='userSpaceOnUse'%20x1='119.9997'%20y1='234.0002'%20x2='119.9997'%20y2='0.0002'%3e%3cstop%20offset='0'%20style='stop-color:%23201F21'/%3e%3cstop%20offset='1'%20style='stop-color:%23313131'/%3e%3c/linearGradient%3e%3crect%20x='-0.0003'%20y='0.0002'%20class='st0'%20width='240'%20height='234'/%3e%3cg%3e%3cpath%20class='st1'%20d='M132.24969,97.95853c-5.60328,18.77988-10.28088,36.91208-15.88416,54.63138%20c-3.18081,9.99579-6.66385,19.53729-11.05544,25.59485c-4.84678,6.81497-13.93402,13.32771-24.83743,13.32771%20c-7.72443,0-15.29683-3.63509-15.29683-11.66174c0-4.99789,5.14901-9.69264,9.23837-9.69264%20c2.42339,0,3.63508,1.36282,4.24046,2.42339c3.7862,6.81497,7.42128,10.75229,9.08724,10.75229s3.02878-2.27135,5.7544-12.1151%20l19.82331-73.26013H99.08337c-1.06058-3.18081,0.45427-7.11812,2.27135-7.87554h14.23625%20c2.72562-8.7841,5.92356-17.60862,10.46719-25.63529c6.81497-12.26713,17.7193-21.95976,32.71205-21.95976%20c11.3586,0,16.05333,5.45216,16.05333,12.41917c-0.15111,7.42036-6.66293,11.20656-9.69263,11.20656%20c-2.42247,0-3.63416-1.81709-4.39159-4.39159c-2.57451-9.69263-5.90643-12.57029-7.87555-12.57029%20c-1.9682,0-4.99789,3.63416-8.3289,11.20656c-4.3925,9.54151-7.28729,19.72977-10.01291,29.72464h17.26501%20c1.05966,2.12023,0.15112,6.66385-2.42339,7.87554H132.24969z'/%3e%3c/g%3e%3c/svg%3e)
Social Profiles
Key Decision Makers
Ray Lareau Chief Technology Officer
David Inman Chief Financial Officer
Sean Boyle Chief Executive Officer
Nathan Rhatigan Senior Vice President of Sales
Amita Shah Vice President of Quality and Regulatory
Lynn Morrison Vice President of Clinical Affairs
Rashmi Prasad Senior Director of Marketing
Sarala Vallabhaneni Clinical Research Associate II
Corwin Belfield Senior Clinical Research Associate